Enerplus: An Attractive Investment For 2013 [View article]
"I have to say I really don't recall things that way"
Well, I'm not looking to argue or nitpick but if one listened to the presentations in the April, 2012, "analyst day" roadshow management was very comfortable with the idea of maintaining the dividend through 2012. I don't see a recording of the oral presentations on the ERF site but you can look at the slides and read between the lines. http://bit.ly/ZQ9qjq
I think most folks thought there was a likelihood that the divi would be decreased in 2013, and I am not criticizing management for cutting but they are not to be trusted, imo.
And don't forget there was an equity raise not that long prior to the analysts day roadshow and they even explain in the presentation slides a bit as to why equity raise was better than a divi reduction.
ERF may do okay longer term, they seem to have a plan in place that may make sense. I just don't trust them.
Enerplus: An Attractive Investment For 2013 [View article]
"Enerplus has made it clear that, despite slow growth the company expects to maintain its dividend"
Well, sure, but during the analyst roadshow they produced in the first part of 2012 they said the same thing and even gave a speciic plan as to how that would be done.....and then cut the dividend a few months later.
You take a risk if you trust management on the dividend question as evidenced by what I just referenced.
SkyPeople: Strong Potential for Fruitful Returns [View article]
Looks like the author took a slow boat to..... as there have been no articles since 2011 and the last instablog six months ago. Maybe went back to continue that on-the-ground research.....
Meanwhile SPU just reported a pretty good quarter and has over $3/share cash on hand. Should be a winner if legit but that on-the-ground report would help determine if legit or not, doncha think....
Well, sure, ERF may be a decent investment for the longer term and I own a rather small amount. But I'll point out it was just a few months before the distribution cut that ERF held a big "analyst's day" presentation explaining how the distribution was likely to be maintained for the remainder of 2012. The path to this was clearly detailed.
I had long held a favorable opinion of management. No longer.
Kewaunee Scientific Corp.: Recipe For A Low Float Rocket [View article]
Thanks for the article. I've watched KEQU for a while, don't own. Can you comment, please, on this from an earlier SA piece... "Second, heavy pension obligations booked to Accumulated Other Comprehensive Income have offset over half of the accumulated retained earnings over the past decade resulting in anemic growth in book value. In other words, much of the reported net income over the past decade has been required to account for pension liabilities rather than to benefit shareholders." http://seekingalpha.co...
You say, "QR Energy has a unique focus on acquiring conventional, mature, domestic assets, targeting long-lasting, stable production rates, which will be accretive to cash distributions to unitholders."
Why do you say it is "unique"? It seems more or less similar to the other upstream MLPs. How is it substantially different from, say, LINE or LGCY?
Aceto Corporation: The Small-Cap Pharma Growth Story That's Got Insiders Buying [View article]
Well, not so fast....
ACET was for many years a specialty chemical company, sourcing from around the world uncommon chemicals that various industries needed in fairly small amounts. They grew steadily over the years and were for many years debt free.
Over time the old management family retired or died off or whatever and new management took on debt, built themselves a fancy new headquarters, and entered into failed initiatives...a generic version of Roundup, animal vaccines.
The company does have potential but management must still prove itself after several missteps. I am a long term holder of this stock, will continue to hold, but not adding at this point.
Analyzing Canadian REITs, Part VII: Retirement, Nursing Homes, Healthcare And Cemeteries [View article]
Your information on Medical Facilities Corp is out of date. They disposed of one of the ambulatory care centers...Barranca...some time ago. The other ambulatory center in Newport Beach is still owned but has mediocre results. The entry into the ambulatory care center market was a mistake. The surgical hospitals and the spine hospital are doing well.
This company is hardly a REIT, however. I am a long term holder and very happy with the company but there are headwinds. The payor mix is a problem as Medicare and Medicaid reimbursements pay much less than necessary to be profitable. The effects of Obamacare are unknown but likely to be troublesome, IMO.
So far as OPTR, the income is basically from selling rights to market their newly approved drug. It is their only commercial product and likely none to follow for sometime. I own it and expect them to do well with this new drug but it is worthwhile to know where the data you use originates.
Labeling and Script Use May Cause Problems For Optimer's New Drug [View article]
Reasonable article in general but when you say, "Of course, there is also the drawback of its recently signed partnership with Astellas (ALPMF.PK), where it entered into an exclusive collaboration and licensing agreement thus lowering its potential revenue and profits." your implication is that this is a general worldwide agreement when it is not. I know that and many OPTR holders do, but the casual reader will be misled.
Why I'm Still Bullish on U.S. Listed China Food Stocks [View article]
Well, sure, there are a number of Chinese food stocks that appear to be great bargains. But how does one decide which are legit?
For example, OINK has good numbers, a good and growing business, and a P/E that is ridiculously low. But just a few days ago Geoinvesting reported that its touted "on the ground research" was impaired (my word, not theirs) when they were brought to the farms but not allowed to enter.
So is OINK a great buy or a scam, or something in between?
How can one tell with regard to a large number of such companies?
Enerplus: An Attractive Investment For 2013 [View article]
Well, I'm not looking to argue or nitpick but if one listened to the presentations in the April, 2012, "analyst day" roadshow management was very comfortable with the idea of maintaining the dividend through 2012. I don't see a recording of the oral presentations on the ERF site but you can look at the slides and read between the lines.
http://bit.ly/ZQ9qjq
I think most folks thought there was a likelihood that the divi would be decreased in 2013, and I am not criticizing management for cutting but they are not to be trusted, imo.
And don't forget there was an equity raise not that long prior to the analysts day roadshow and they even explain in the presentation slides a bit as to why equity raise was better than a divi reduction.
ERF may do okay longer term, they seem to have a plan in place that may make sense. I just don't trust them.
Enerplus: An Attractive Investment For 2013 [View article]
Well, sure, but during the analyst roadshow they produced in the first part of 2012 they said the same thing and even gave a speciic plan as to how that would be done.....and then cut the dividend a few months later.
You take a risk if you trust management on the dividend question as evidenced by what I just referenced.
SkyPeople: Strong Potential for Fruitful Returns [View article]
Meanwhile SPU just reported a pretty good quarter and has over $3/share cash on hand. Should be a winner if legit but that on-the-ground report would help determine if legit or not, doncha think....
Enerplus: Primed For A Rebound [View article]
I had long held a favorable opinion of management. No longer.
FWIW.
Kewaunee Scientific Corp.: Recipe For A Low Float Rocket [View article]
"Second, heavy pension obligations booked to Accumulated Other Comprehensive Income have offset over half of the accumulated retained earnings over the past decade resulting in anemic growth in book value. In other words, much of the reported net income over the past decade has been required to account for pension liabilities rather than to benefit shareholders."
http://seekingalpha.co...
QR Energy - Not Your Typical MLP [View article]
Why do you say it is "unique"? It seems more or less similar to the other upstream MLPs. How is it substantially different from, say, LINE or LGCY?
Aceto Corporation: The Small-Cap Pharma Growth Story That's Got Insiders Buying [View article]
ACET was for many years a specialty chemical company, sourcing from around the world uncommon chemicals that various industries needed in fairly small amounts. They grew steadily over the years and were for many years debt free.
Over time the old management family retired or died off or whatever and new management took on debt, built themselves a fancy new headquarters, and entered into failed initiatives...a generic version of Roundup, animal vaccines.
The company does have potential but management must still prove itself after several missteps. I am a long term holder of this stock, will continue to hold, but not adding at this point.
Optimer Pharma: 2 Potentially Potent Drugs In The Pipeline [View article]
Don't think so. It's all about fida. They also had a quinalone which they withdrew not long ago and a ketolide which I believe has gone nowhere.
It's fida or bust. I have a smallish long position.
Analyzing Canadian REITs, Part VII: Retirement, Nursing Homes, Healthcare And Cemeteries [View article]
This company is hardly a REIT, however. I am a long term holder and very happy with the company but there are headwinds. The payor mix is a problem as Medicare and Medicaid reimbursements pay much less than necessary to be profitable. The effects of Obamacare are unknown but likely to be troublesome, IMO.
Still, I would add at the "right" price.
Marine Harvest's Earnings Restatement Could Be Buying Opportunity; Use Caution [View article]
Squeeze Ideas: 4 Highly Profitable, Oversold Stocks With Increasing Shorts [View article]
Labeling and Script Use May Cause Problems For Optimer's New Drug [View article]
Of course it is an important issue. Not to mention efficacy means producing a desired result....and a desired result is cure without recurrance.
Labeling and Script Use May Cause Problems For Optimer's New Drug [View article]
I'm long and happy....
Why I'm Still Bullish on U.S. Listed China Food Stocks [View article]
For example, OINK has good numbers, a good and growing business, and a P/E that is ridiculously low. But just a few days ago Geoinvesting reported that its touted "on the ground research" was impaired (my word, not theirs) when they were brought to the farms but not allowed to enter.
So is OINK a great buy or a scam, or something in between?
How can one tell with regard to a large number of such companies?
Risky business....
Cal-Maine Foods: Profit Opportunity in the Egg Business [View article]
I have no position in CALM at this time.